Market Tracker

10/30 8:39am ET

Novavax Inc (NASDAQ:NVAX)

Wednesday’s Trading Day
5.41 -0.07 / -1.28%
Data as of Oct 29
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
5.71 +0.30 / +5.55%
 
Volume: 67.8K

Today’s Trading

Previous close5.48
Today’s open5.50
Day’s range-- - 5.55
Volume5,015,265
Average volume (3 months)3,780,417
Market cap$1.3B
Dividend yield--
Data as of 10/29/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+5.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+0.26+0.65%
KITEKite Pharma Inc-0.65-1.77%
HALOHalozyme Therapeutic...-0.05-0.53%
BLUEbluebird bio Inc-1.35-3.29%
Data as of 10/29/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts